SELECTIS HEALTH, INC. Material Event: Asset Divestiture

If you follow Selectis Health, Inc., you may have seen the recent news. The company just finalized a major deal, and I have broken down what it means for you in plain English.

1. What happened?

On May 1, 2026, Selectis Health sold two skilled nursing facilities: Glen Eagle Healthcare and Rehab in Abbeville, Georgia, and Eastman Healthcare and Rehab in Eastman, Georgia.

The company sold both the property and the operations of these facilities. Selectis received about $9 million in cash after paying off the mortgages and debts tied to the buildings. They also have $1.57 million held in an escrow account, which they will receive only if they meet specific post-closing conditions.

2. Why did it happen?

Selectis is looking to simplify its business model. By selling these facilities, they are offloading assets they no longer view as central to their long-term mission. The primary goal here was to raise cash quickly and pay off the mortgage debt associated with these specific properties, effectively cleaning up the balance sheet.

3. Why does this matter for your portfolio?

This move changes the company’s financial profile. Selectis has traded the steady, long-term income from these nursing homes for an immediate cash infusion and lower debt obligations. For investors, this creates a "smaller" company. While the debt load is lower, the company has also permanently reduced its capacity to generate total revenue from these Georgia locations.

4. What should you look for next?

• Watch the "Pro Forma" Reports: In upcoming financial filings, the company will provide "pro forma" statements. These remove the past performance of the Glen Eagle and Eastman facilities. This is the most important document to watch, as it will show you the company’s "new" baseline performance without the noise of these sold assets.
• Analyze Profit Margins: Now that the debt is lower, check to see if the company’s profit margins actually improve. If the interest savings don't outweigh the lost revenue from these facilities, the sale may not be as beneficial as it appears on the surface.
• Monitor the Escrow: Keep an eye out for updates on that $1.57 million in escrow. If the company meets those post-closing conditions, that’s a nice bit of extra cash hitting the books.

5. The Bottom Line

Selectis Health is currently an "emerging growth company," which means they are still in an early stage of development and have fewer reporting requirements than larger healthcare corporations.

When evaluating this move, ask yourself: Does this sale make the company more focused and profitable, or did they just sell off a reliable revenue stream to cover debt? The market will take time to adjust to this new, smaller version of Selectis, so don't be surprised if you see some volatility in the stock price as investors digest these changes.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and is not professional investment advice. Always do your own research and consult with a qualified professional before making financial decisions.